Community Chat: Looking for safe, high-yield dividends in energy? Tired of volatile stocks? Want steady cash flow from monopoly-like infrastructure? This combo is for you! The United States boasts roughly 3 million miles of pipelines that carry natural gas and liquid fuels to power plants, refineries, businesses, and millions of households. These pipelines are not only the “arteries” of the nation’s energy supply but also offer investors a relatively stable high-dividend sector. Unlike oil and gas producers, midstream energy companies make money mainly by charging fees for transportation and storage, resulting in highly stable revenue and predictable cash flow. Against a backdrop of rebounding energy demand, a number of pipeline companies are increasing capital spending to expand their net

💬 Income investors: Do you prefer monthly dividends? Which Canadian monthly payers are in your portfolio? Let’s share! Finding monthly dividend stocks in Canada is getting harder. Most companies have shifted to quarterly payouts, leaving cash-flow-focused investors frustrated. Yet a small number of firms, thanks to their unique business models, still pay dividends every single month — making them “rare gems” for passive income seekers. This article breaks down three monthly dividend stocks with both defensive strength and growth potential, from three resilient sectors: retirement real estate, aviation services, and industrial logistics. 1. $Chartwell Retirement Residences(CWSRF)$– The Retirement Rent King Under Canada’s Aging Wave

💬 GLP-1 investors: Tired of only giants dominating the weight-loss space? Think small-cap biotechs can still deliver 10-bagger returns? Which under-the-radar name is on your watchlist? While global drugmakers flood into the GLP-1 sector, and giants build deep moats with tens of billions in annual revenue, one small biotech company with a $4 billion market cap is quietly approaching its “moment of truth.” $Viking Therapeutics(VKTX)$ has no approved products yet, but its core pipeline drug VK2735 is hitting a critical inflection point. The company plans to release clinical data for the drug as a maintenance dose in the third quarter of this year. If the results are positive, this small-to-mid-sized biotech could see a short-term pric

🔥 Clean tech miners — are you watching tailure recovery plays?🤝 What’s your top pick for mine waste recycling in 2026? Let’s talk metallurgy talent and commercial-scale project delivery! VANCOUVER, BC, March 30, 2026 (GLOBE NEWSWIRE) — $EnviroGold Global Limited(ESGLF)$, a clean technology company focused on recovering precious and critical metals from mine waste and tailings, is pleased to announce the appointment of Dr. Greg O’Connor as Chief Metallurgical Engineer. Dr. O’Connor will be based at the Company’s project development hub in Western Australia and will support advancement through EnviroGold’s Rapid Deployment Pathway toward commercial partnerships and full-scale deployment. Dr. O’Connor brings over 30 years of experien

💬 Gold traders & macro investors: DXY >100, oil >$100… and gold is RISING? Is this the new inflation hedge playbook? Let’s debate! $Gold - main 2606(GCmain)$On Monday, the U.S. Dollar Index closed at 100.57 and crude oil futures climbed above $102.88 per barrel — both breaking the 100 level at the same time. By traditional trading logic, this is a double bearish signal for gold: A stronger dollar raises costs for non-U.S. buyers, while a sharp crude oil spike usually sparks fears of tighter liquidity first. Yet gold rose for five straight sessions, settling at $4,540 — up 2.84% in total. This unusual move is forcing traders to rethink gold’s pricing model. Why Did the Traditional Playbook Fail? The textbook says: Stro

💬 Critical minerals & defense investors: The U.S. has just 2 months of rare earths left — is this the biggest supply crunch of 2026? Let’s discuss! Why is the U.S. pouring billions into uncommercialized rare earth startups, even accepting controversy and technical failures?$S&P 500(.SPX)$ The blunt, existential answer comes from an industry report: the U.S. has only two months of strategic rare earth stockpiles left. Heavy rare earths such as dysprosium and terbium — core materials for missile guidance, radar, and stealth jets — are especially vulnerable. Meanwhile, recent U.S. operations in the Middle East burned through about $5.6 billion worth of high-precision munitions in just two days, draining rare earths far faster

💬 Growth investors: Are you hunting for bargains in this pullback? Which beaten-up tech stock is on your buy list? Let’s share! The outbreak of the Iran conflict has sent violent shockwaves through global financial markets. The Dow Jones Industrial Average and the Nasdaq have both plunged more than 10% from recent highs, officially entering correction territory. After hitting a record closing high in late January, the S&P 500 has slid roughly 9.4% — teetering right on the edge of a correction. Meanwhile, oil prices have surged, the crisis over the Strait of Hormuz looms large, and fears of a global recession are growing rapidly. Yet history repeatedly shows: every double-digit market drop is almost always a great buying opportunity for long-term investors. Even as panic dominates short

LLY holders, how’s the pain? Strong earnings but stock stuck in the dumps! Is this the bottom? And will Medicare finally cover weight-loss drugs and light a fire under Lilly? Let’s talk! $Eli Lilly(LLY)$ has delivered impressive financial results in recent years. The leading healthcare company owns two high-performing GLP--1 drugs, Zepbound and Mounjaro, used for obesity and diabetes respectively, and demand has been strong among patients looking to lose weight and improve their health. But Lilly’s growth story is about much more than these two drugs. Expanding profit margins show the company is growing sales much faster than expenses, which likely means Lilly is producing drugs more efficiently. Management confirmed this view in re

Under normal circumstances, the trend of stock market determines the direction of the individual stock. To be more specific, 3 of the 4 stocks follow the direction of the market. In addition, the trend of the broad index is also consistent. For example, if small-cap stocks rise, the Nasdaq and larger-cap stocks also rise.With this in mind, the U.S. stock market in 2023 is very special, with serious differentiation. Most major stock indexes are still up year-to-date, but 60% of stocks are trading below their 200-day moving average. $iShares Russell 2000 ETF(IWM)$ fell 0.5%, while the $SPDR S&P 500 ETF Trust(SPY)$ rose 8% over the same period, while the tech-heavy $In